Sjögren's syndrome is a systemic inflammatory rheumatic disorder of unknown origin with so
far inadequate therapy options. Management of Sjögren's syndrome is still primarily …

Primary Sjögren's Syndrome (PSS) is characterized by dryness of the eyes and mouth due
to lymphocytic infiltration of secretory exocrine glands. As well as disabling dryness, patients …

Opinion statement Primary Sjögren's syndrome (pSS) is an autoimmune disease, showing a
broad heterogeneity concerning the symptoms, the involved organs, as well as the …

How to assess treatment efficacy in Sjögren's syndrome? : Current Opinion in Rheumatology
How to assess treatment efficacy in Sjögren's syndrome? : Current Opinion in Rheumatology …

The authors focus on the role of B cells in the pathogenesis of a heterogeneous disease
known as Sjögren's syndrome (SS). They discuss the effectiveness of a potent biologic …

Published studies and trials of oral and biologic disease-modifying antirheumatic drugs for
the treatment of Sjögren's syndrome have shown disappointing results. Improvements in trial …

Primary Sjögren syndrome (SjS) is a systemic autoimmune disease that may affect 1 in 1000
people (overwhelmingly women) and that can be a serious disease with excess mortality …

Although Sjögren's syndrome is an autoimmune disorder, immunosuppressive agents have
yielded disappointing results in clinical trials. In this paper we summarize our experience …

Objective: To investigate the safety and efficacy of rituximab (RTX) for systemic symptoms in
patients with primary Sjögren's syndrome (pSS), and changes in B cell biomarkers. Patients …

Purpose of review Sjögren's syndrome (SS) is an autoimmune disease characterized by
sicca symptoms, musculoskeletal pain, and systemic manifestations. Biologic therapies have …